Dr. Ramez N. Eskander, is a Clinical Professor of Gynecologic Oncology at the UC San Diego Moores NCI Designated Comprehensive Cancer Center. Dr. Eskander also serves as the Medical Director of the UC San Diego Moores Cancer Center Clinical Trials Office and is the Gynecologic Oncology Fellowship Director. He specializes in the management of ovarian, uterine, cervical, vulvar and vaginal cancer. His expertise includes clinical trials and drug development, precision medicine, biomarker directed therapy and therapeutic/surgical procedures.

Dr. Eskander is an experienced clinical trialist, with over 14 years of experience in both the development of early and late-stage clinical trials, as well as the conduct and completion of gynecologic cancer studies. He currently leads several international clinical trials examining novel therapeutic strategies in the management of gynecologic malignancies.

Dr. Eskander has co-authored over 130 peer-reviewed articles, several book chapters and is the co-editor of Gynecologic Oncology: A Pocketbook. His work has been published in journals such as The New England Journal of Medicine, Journal of Clinical Oncology, Nature Medicine, Annals of Oncology, Clinical Cancer Research, JAMA Oncology, Obstetrics and Gynecology, and Gynecologic Oncology, among others. Dr. Eskander’s work helped established a new standard of care in the treatment of patients with advanced stage and recurrent endometrial cancer.

As a Professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences, Dr. Eskander instructs medical students, residents and fellows at University of California San Diego, School of Medicine. His research focuses on immunotherapy, targeted therapies, cell therapy, novel drug combinations, epigenetics, and molecular diagnostics.

Dr. Eskander completed a fellowship in gynecologic oncology at UC Irvine School of Medicine and a residency in obstetrics and gynecology at UC San Diego School of Medicine, where he also earned his medical degree.